Role of antibody and indirect antigen presentation in transplant-associated coronary artery vasculopathy.
Rose
M L
ML
Heart Science Centre, National Heart and Lung Institute, Harefield Hospital, Middlesex, United Kingdom.
D000818:Animals; D000917:Antibody Formation; D000918:Antibody Specificity; D017951:Antigen Presentation; D001327:Autoimmune Diseases / Q000276:immunology; D003327:Coronary Disease / Q000209:etiology / Q000276:immunology*; D016207:Cytokines / Q000276:immunology; D004730:Endothelium, Vascular / Q000276:immunology; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006680:HLA Antigens / Q000276:immunology; D016027:Heart Transplantation / Q000009:adverse effects / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology
D016207:Cytokines; D006680:HLA Antigens; D007166:Immunosuppressive Agents